3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effects of growth hormone and prolactin immune development and function.

      1 , ,
      Life sciences

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Growth hormone and prolactin are neuroendocrine hormones that exert numerous effects on immune system function and development. Several fundamental questions are addressed in this review. Do neuroendocrine hormones affect specific immune cell types? What is the physiological significance of these effects? Can these effects be exploited clinically? While it is clear that there are indeed significant interactions between the neuroendocrine and immune systems, there are relatively few examples with demonstrated physiological significance. Present studies indicate that growth hormone and prolactin may exert markedly different effects on immune cell types depending on their stage in differentiation. Recent emphasis has also been focussed on the use of these hormones or their antagonists clinically in the treatment of AIDS, cancer, and autoimmune disease states due to their pleiotropic effects and low toxicity after systemic administration. However, we do not yet have a clear picture of how the influence of neuroendocrine hormones may be used to favorably alter pathophysiologic processes affecting immune function and development.

          Related collections

          Author and article information

          Journal
          Life Sci.
          Life sciences
          0024-3205
          0024-3205
          1995
          : 57
          : 1
          Affiliations
          [1 ] Biological Carcinogenesis and Development Program, Program Resources, Inc./Dyn Corp, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.
          Article
          002432059500237Z
          7596216
          ae885229-4acf-4ff8-aada-6e4a91af3bfa
          History

          Comments

          Comment on this article